Clinical Cancer Research Grant

    From Rising Tide Foundation

    Rising Tide Foundation promotes freedom and prosperity for all, advocating for a market economy, limited government, and the rule of law. They believe in individual flourishing through voluntary exchange and aim to address poverty by respecting individual dignity and moral agency. Their goal is to support projects that eliminate obstacles for creative individuals, offering a "hand up" instead of a "hand-out," and oppose big-government and crony capitalism interventions.

    Type of Support

    Overview

    The grant program is guided by principles of patient involvement, aiming to establish a new norm in clinical cancer research that treats patients as partners. It supports interventional clinical trials not funded by commercial entities, with a requirement for research to show patient impact within 3 to 5 years and to start within 6 months of award notification. The funding approach is rooted in patient centricity, ensuring research aligns with improving patient quality of life. Projects should focus on short time frames for maximum impact, and align with strategic focus areas developed with expert input. These areas include improving patient outcomes with minimal toxicity, enhancing early detection and intervention, and advancing research in underserved regions. The foundation encourages partnerships to maximize reach and expects co-funding plans from applicants. Specific focus areas include therapy optimization, disease and treatment burden, implementation research, early detection, early intervention, and advancing cancer research in Sub-Saharan Africa.

    Eligibility

    Organization's Location
    laborum adipisicing
    Program Location
    quis
    Organization Type
    Ad minim
    Lorem ipsum
    Other
    • est anim dolore sit sunt velit amet
    • tempor dolor quis quis mollit do nostrud ullamco nostrud exercitation aliquip aute
    • commodo magna deserunt fugiat fugiat excepteur occaecat exercitation et elit
    • aliqua quis aute aliquip pariatur ullamco anim proident est excepteur irure do
    • tempor nulla nisi enim deserunt aliqua eiusmod veniam labore eu duis occaecat

    Submission

    Schedule
    Step 1: enim proident minim
    Application deadline
    Aug 24, 2026
    Step 2: dolore veniam (nulla laborum)